Latest share price

Current

865.00p

Average

+16.00p LSE

+1.88% 15 min delay

View chart

Results, reports & presentations

Our financial reports, corporate presentations, webcasts and audio can be found in this section.

Go

Latest press releases

23/11/2020

Oxford Biomedica notes AstraZeneca’s AZD1222 met primary efficacy endpoint in...

Read more

23/11/2020

Oxford Biomedica Appoints Dr. Sam Rasty as Non-Executive Director

Read more

09/11/2020

Oxford Biomedica and PhoreMost enter gene therapy discovery collaboration

Read more

See all

Regulatory news

Message from the CEO
John Dawson

 

Message from the CEO 
John Dawson

Management and DirectorsGo

Shareholder meetings, circulars, and prospectusesGo

Analyst coverageGo

Corporate governanceGo

Financial calendarGo

Investor contactsGo

Email alertsGo